Publications Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials Citation Pai RK, Kleiner DE, Hart J, Adeyi OA, Clouston AD, Behling CA, Jain D, Kakar S, Brahmania M, Burgart L, Batts KP, Valasek MA, Torbenson MS, Guindi M, Wang HL, Ajmera V, Adams LA, Parker CE, Feagan BG, Loomba R, Jairath V. Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials. Aliment Pharmacol Ther. 2019 Nov;50(10):1100-1111. doi: 10.1111/apt.15503. Epub 2019 Oct 3. PMID: 31583739; PMCID: PMC6817398. Abstract Background: There is substantial variation in how histologic definitions and scoring systems of non-alcoholic fatty liver disease (NAFLD) are operationalised. Tags Biopsy, Liver, Liver Cirrhosis, NAFLD, Non-alcoholic Fatty Liver Disease, Pathology Read More
